DUBLIN--(BUSINESS WIRE)--The "Bioabsorbable Stents Market - Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
Despite the progression in normal metallic stents, there have been concerns on stent thrombosis and mismatch of stent with vessel size. To overcome these roadblocks biodegradable stents came into existence in the recent years and is expected to considerably replace traditional stents. They eradicate the need for dual anti-platelet therapies and treat coronary artery diseases more efficiently.
Bioabsorbable implant stents can be used as a delivery device for agents such as drugs and genes, and will perhaps play a role in the treatment of vulnerable plaque. Increasing occurrences of coronary and peripheral artery diseases coupled with increased commercialization of these products especially in the developed nations is driving the growth of the market. This market report is classified on the basis of various parameters. This report contains market segments categorized on the basis of material, application, end user and geography. The bioabsorbable stents market is classified on the basis of material used for manufacturing the products including polymeric and metallic.
Increasing focus on clinical trials of stents, aging population and technological advancements in treatments are the key drivers for the market growth. Metal bioabsorbable stents are luring the medical device providers as they have the potential to perform similarly to stainless steel metal stents. So far, two bioabsorbable metal alloys have been commercialized for this application: iron and magnesium. Zinc is being investigated and has been proven more efficient with fewer side effects. North America and Europe held major shares due to product availability, high standards of healthcare and constant innovation related to stents.
The key players in bioabsorbable stents market include:
- Abbot Laboratories
- Elixir Medical Corporation
- Reva Medical, Inc.
- Kyoto Medical Planning Co., Ltd.
Key Topics Covered:
1. Bioabsorbable Stents Market Overview
1.1. Introduction
1.2. Classification
2. Executive Summary
3. Bioabsorbable Stents Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. Patent Analysis
3.2.3. Financials of Key Players
4. Bioabsorbable Stents Market Forces
4.1. Market Drivers
4.2. Market Constraints & Challenges
4.3. Attractiveness of the Industry
4.3.1. Suppliers Power
4.3.2. Bargaining Power of Buyer
4.3.3. Threat from New Entrants
4.3.4. Threats from Substitutes
4.3.5. Degree of Competition
5. Bioabsorbable Stents Market - Strategic Analysis
5.1. Supply Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
6. Bioabsorbable Stents Market- By Material
6.1. Polymeric Stents
6.2. Metallic Stents
6.2.1. Iron
6.2.2. Zinc
6.2.3. Magnesium
7. Bioabsorbable Stents Market- By Application
7.1. Coronary Artery Disease
7.2. Peripheral Artery Disease
8. Bioabsorbable Stents Market- By End-User
8.1. General Hospitals
8.2. Cardiac Centers
8.3. Surgical Centers
9. Bioabsorbable Stents Market-Geographic Analysis
10. Market Entropy
11. Company Profiles (Overview, Financials, Developments and Product Portfolio)
11.1. Abbott Laboratories
11.2. Elixir Medical Corporation
11.3. Boston Scientific Corporation
11.4. Kyoto Medical Planning Co., Ltd.
11.5. Amaranth Medical, Inc.
11.6. REVA Medical, Inc.
11.7. Biotronik SE & Co. KG
11.8. Arterial Remodelling Technologies SA
11.9. Meril Life Sciences Pvt. Ltd.
11.10. Tepha Inc.
11.11. Arterius Limited
For more information about this report visit https://www.researchandmarkets.com/r/vw1sqs
